Kurt Krapfenbauer

Advanced proteomics procedure as a detection tool for predictive screening in type 2 pre-Diabetes

K. Krapfenbauer, Jadranka Koehn, Kurt Krapfenbauer, 2010, EPMA Journal.

Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders

Gert Lubec, N. Cairns, G. Lubec, 2003, Brain Research.

Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine

E. Drucker, K. Krapfenbauer, Kurt Krapfenbauer, 2013, EPMA Journal.

Proteomics in brain research: potentials and limitations

Gert Lubec, G. Lubec, K. Krapfenbauer, 2003, Progress in Neurobiology.